Myriad Genetics, Inc. · NASDAQ:MYGN
The Vanguard Group reported a 8.47% stake in Myriad Genetics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 31, 2025
The Vanguard Group reported a 8.47% stake in Myriad Genetics, Inc., 7,882,515 shares, as a passive investor on Sep 30, 2025. Filed Oct 31, 2025 (Schedule 13G/A).
- Stake
- 8.47%
- Shares
- 7,882,515
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 8.47% | 7,882,515 |
Source
Related
- Myriad Genetics, Inc.
- The Vanguard Group
- Myriad Genetics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · The Vanguard Group · Jul 29, 2025
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Sep 4, 2026
- Form 4 · Wheeler Benjamin Richard · Aug 17, 2026